Yuejin Li Selected Research

N,N'-dinitrosopiperazine

1/2022	Retraction Note: Proteomic analysis on N, N'-dinitrosopiperazine-mediated metastasis of nasopharyngeal carcinoma 6-10B cells.
1/2022	Retraction Note: Identification of novel signaling components in N,N'-Dinitrosopiperazine-mediated metastasis of nasopharyngeal Carcinoma by quantitative phosphoproteomics.
12/2018	Dinitrosopiperazine-decreased PKP3 through upregulating miR-149 participates in nasopharyngeal carcinoma metastasis.
2/2016	Clusterin induced by N,N'-Dinitrosopiperazine is involved in nasopharyngeal carcinoma metastasis.
11/2014	Dinitrosopiperazine-mediated phosphorylated-proteins are involved in nasopharyngeal carcinoma metastasis.
1/2014	N,N'-dinitrosopiperazine-mediated AGR2 is involved in metastasis of nasopharyngeal carcinoma.
1/2014	Identification of novel signaling components in N,N'-dinitrosopiperazine-mediated metastasis of nasopharyngeal carcinoma by quantitative phosphoproteomics.
1/2013	N,N'-dinitrosopiperazine--mediated heat-shock protein 70-2 expression is involved in metastasis of nasopharyngeal carcinoma.
11/2012	Proteomic analysis on N, N'-dinitrosopiperazine-mediated metastasis of nasopharyngeal carcinoma 6-10B cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuejin Li Research Topics

Disease

18	Neoplasm Metastasis (Metastasis) 01/2022 - 11/2012
15	Neoplasms (Cancer) 01/2022 - 01/2014
10	Nasopharyngeal Carcinoma 01/2022 - 11/2012
8	Carcinogenesis 11/2020 - 03/2014
7	Colorectal Neoplasms (Colorectal Cancer) 12/2021 - 02/2016
4	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 05/2014
3	Inflammation (Inflammations) 01/2022 - 12/2019
3	Infections 05/2015 - 05/2014
2	Colonic Neoplasms (Colon Cancer) 01/2022 - 05/2019
2	Heart Diseases (Heart Disease) 01/2022 - 04/2014
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 12/2019
2	Obesity 01/2020 - 11/2018
2	Stomach Neoplasms (Stomach Cancer) 01/2019 - 12/2018
2	Leukemia 01/2019 - 05/2014
2	Heart Failure 09/2017 - 09/2013
2	Cholangiocarcinoma 11/2016 - 01/2016
2	Hypoxia (Hypoxemia) 01/2013 - 01/2011
2	Restrictive Cardiomyopathy 09/2010 - 06/2008
1	Metabolic Diseases (Metabolic Disease) 01/2022
1	Endoleak 08/2021
1	Hypertension (High Blood Pressure) 02/2021
1	Dementia (Dementias) 02/2021
1	Type 2 Diabetes Mellitus (MODY) 02/2021
1	Dyslipidemias (Dyslipidemia) 02/2021
1	Ischemic Stroke 02/2021
1	Cognitive Dysfunction 01/2021
1	COVID-19 01/2021
1	Pathologic Processes 11/2020
1	Atherosclerotic Plaque (Atheroma) 05/2020
1	Abdominal Aortic Aneurysm 05/2020
1	Body Weight (Weight, Body) 01/2020
1	Chronic Disease (Chronic Diseases) 01/2020
1	Disease Susceptibility (Diathesis) 01/2020
1	Hyperplasia 01/2020
1	Insulin Resistance 01/2020
1	Virus Diseases (Viral Diseases) 01/2020
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2019
1	Hyperuricemia 12/2019
1	Gout 12/2019
1	Non-alcoholic Fatty Liver Disease 01/2019

Drug/Important Bio-Agent (IBA)

9	N,N'-dinitrosopiperazineIBA 01/2022 - 11/2012
6	Biomarkers (Surrogate Marker)IBA 02/2021 - 02/2016
5	Pharmaceutical PreparationsIBA 01/2022 - 05/2014
5	Immunoglobulin G (IgG)IBA 02/2021 - 12/2019
5	CarcinogensIBA 11/2020 - 01/2014
5	Proteins (Proteins, Gene)FDA Link 01/2017 - 11/2012
4	UbiquitinIBA 12/2021 - 01/2018
3	Polysaccharides (Glycans)IBA 02/2021 - 12/2019
3	CateninsIBA 05/2019 - 01/2017
3	MicroRNAs (MicroRNA)IBA 11/2018 - 01/2016
3	Troponin IIBA 09/2017 - 06/2008
2	Nicotinamide PhosphoribosyltransferaseIBA 01/2022 - 11/2018
2	Methionine (L-Methionine)FDA Link 01/2021 - 01/2018
2	DNA (Deoxyribonucleic Acid)IBA 11/2020 - 01/2020
2	InterleukinsIBA 01/2020 - 03/2014
2	Uric Acid (Urate)IBA 12/2019 - 01/2019
2	Adenosine Triphosphate (ATP)IBA 12/2018 - 11/2014
2	Messenger RNA (mRNA)IBA 01/2017 - 01/2016
2	ClusterinIBA 02/2016 - 11/2012
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2016 - 11/2014
2	PhosphoproteinsIBA 11/2014 - 01/2014
2	Small Interfering RNA (siRNA)IBA 05/2014 - 03/2014
1	TeaIBA 01/2022
1	AcetylglucosamineIBA 02/2021
1	LectinsIBA 01/2021
1	TransferasesIBA 01/2021
1	Untranslated RNA (Noncoding RNA)IBA 11/2020
1	Biological ProductsIBA 11/2020
1	Hormones (Hormone)IBA 05/2020
1	Insulin-Like PeptidesIBA 05/2020
1	Glutathione PeroxidaseIBA 01/2020
1	kukoamine BIBA 01/2020
1	Blood Glucose (Blood Sugar)IBA 01/2020
1	CatalaseIBA 01/2020
1	ChromatinIBA 01/2020
1	EnzymesIBA 01/2020
1	FructoseIBA 01/2020
1	Insulin (Novolin)FDA Link 01/2020
1	LipidsIBA 01/2020
1	Malondialdehyde (Propanedial)IBA 01/2020
1	Superoxide DismutaseIBA 01/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020
1	CytokinesIBA 01/2020
1	Therapeutic UsesIBA 01/2020
1	Immunoglobulins (Immunoglobulin)IBA 12/2019
1	A-factor (Streptomyces)IBA 12/2019
1	AlkaloidsIBA 05/2019
1	brucineIBA 05/2019
1	StrychnineIBA 05/2019
1	Antineoplastic Agents (Antineoplastics)IBA 05/2019
1	Sorafenib (BAY 43-9006)FDA Link 01/2019
1	Nucleic AcidsIBA 01/2019
1	regorafenibIBA 01/2019
1	p38 Mitogen-Activated Protein KinasesIBA 01/2019

Therapy/Procedure

5	Therapeutics 11/2020 - 10/2016
1	Stents 08/2021
1	Aftercare (After-Treatment) 01/2020
1	Precision Medicine 01/2020
1	Traditional Medicine (Folk Remedies) 05/2019
1	Immunotherapy 01/2019